Peripheral Artery Disease

Patients unsuitable for revascularisation are frequently studied.

Studied for new capillary formation.

Multiple pilot trials exist.

Reported adverse events are mostly local — swelling, pain, or bruising at the harvest and injection sites. Infection and cell-processing quality remain the key risks to monitor.

Existing studies are limited by sample size, methodology, and follow-up, and SVF preparation differs substantially between centres, making cross-study comparison difficult.